Literature DB >> 18519925

In the clinic. Hepatitis C.

Janice H Jou, Andrew J Muir.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18519925      PMCID: PMC5144161          DOI: 10.7326/0003-4819-148-11-200806030-01006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  52 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

Review 2.  The therapeutic use of acetaminophen in patients with liver disease.

Authors:  Gordon D Benson; Raymond S Koff; Keith G Tolman
Journal:  Am J Ther       Date:  2005 Mar-Apr       Impact factor: 2.688

3.  Hepatitis C - contamination of toothbrushes: myth or reality?

Authors:  G Lock; M Dirscherl; F Obermeier; C M Gelbmann; C Hellerbrand; A Knöll; J Schölmerich; W Jilg
Journal:  J Viral Hepat       Date:  2006-09       Impact factor: 3.728

4.  An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic.

Authors:  Alexandre Macedo de Oliveira; Kathryn L White; Dennis P Leschinsky; Brady D Beecham; Tara M Vogt; Ronald L Moolenaar; Joseph F Perz; Thomas J Safranek
Journal:  Ann Intern Med       Date:  2005-06-07       Impact factor: 25.391

5.  Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

Authors:  Gary L Davis; John B Wong; John G McHutchison; Michael P Manns; Joann Harvey; Janice Albrecht
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

Review 6.  Rapid virologic response: a new milestone in the management of chronic hepatitis C.

Authors:  Fred Poordad; K Rajender Reddy; Paul Martin
Journal:  Clin Infect Dis       Date:  2008-01-01       Impact factor: 9.079

7.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

8.  Hepatitis C virus infection in healthcare workers: risk of exposure and infection.

Authors:  B P Lanphear; C C Linnemann; C G Cannon; M M DeRonde; L Pendy; L M Kerley
Journal:  Infect Control Hosp Epidemiol       Date:  1994-12       Impact factor: 3.254

9.  Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.

Authors:  Alejandro Soza; James E Everhart; Marc G Ghany; Edward Doo; Theo Heller; Kittichai Promrat; Yoon Park; T Jake Liang; Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more
  4 in total

1.  Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique.

Authors:  Sung Ui Shin; Jeong-Min Lee; Mi Hye Yu; Jeong Hee Yoon; Joon Koo Han; Byung-Ihn Choi; Kevin J Glaser; Richard L Ehman
Journal:  Radiology       Date:  2014-03-09       Impact factor: 11.105

2.  Hepatitis C in haematological patients.

Authors:  Y Y Hwang; R H S Liang
Journal:  Hepat Res Treat       Date:  2010-08-25

3.  Seroprevalence of anti-HCV antibodies among blood donors of north India.

Authors:  R N Makroo; Rimpreet Singh Walia; Mohit Chowdhry; Aakanksha Bhatia; Vikas Hegde; N L Rosamma
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

4.  Direct quantitative analysis of HCV RNA by atomic force microscopy without labeling or amplification.

Authors:  Yu Jin Jung; Jeffrey A Albrecht; Ju-Won Kwak; Joon Won Park
Journal:  Nucleic Acids Res       Date:  2012-10-16       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.